KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 #stocksoftheday #stockalert #stocknews #event #phase1/2 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!